US Stock MarketDetailed Quotes
ARQT Arcutis Biotherapeutics
- 14.300
- -0.630-4.22%
Close Dec 27 16:00 ET
- 14.300
- 0.0000.00%
Post 20:01 ET
1.67BMarket Cap-8.56P/E (TTM)
15.030High14.195Low1.59MVolume14.880Open14.930Pre Close22.98MTurnover1.89%Turnover RatioLossP/E (Static)117.04MShares15.79052wk High10.69P/B1.21BFloat Cap3.07052wk Low--Dividend TTM84.30MShs Float40.880Historical High--Div YieldTTM5.59%Amplitude1.760Historical Low14.453Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Arcutis Biotherapeutics Stock Forum
Arcutis Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(9.38%),David Rosen(9.38%)
Long-term! 😜
1 MINUTE AGO, 8:20 AM EDT
VIA GLOBENEWSWIRE
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types | ARQT Stock News
No comment yet